Form CORRESP - Correspondence:
SEC Accession No. 0001104659-19-044955
Filing Date
2019-08-08
Accepted
2019-08-08 17:23:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 47950
2 GRAPHIC g96356bmi001.jpg GRAPHIC 2500
  Complete submission text file 0001104659-19-044955.txt   52504
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations